Ngamionline [Pty] Ltd

Business Type:Retailer

Main Products:Hospital Beds,Gamorra Vivva Po4223+ AIDS CURE

Country/Region:Botswana

Annual Revenue:10000 USD

Year Established:2013

Main Markets:North America,Africa,Mid East,Eastern Asia,

Ddu Verified

HOT Rank

8/10
Company Information

Other Products: 

wheelchairs,walking aids,electric wheelchairs,hospital beds,shower chairs,rehabilitation medical products,nursing beds, Antiviral,Antibacterial Agents, Antimicrobial formulations, Contraceptives, Surgical Instruments, First AID (Diagnostic), Oral and Dental.


New Product:

GAMMORA VIVVA PO4223+ HIV/ AIDS CURE:
This is a brand new approved and tested final cure for HIV/AIDS. It's a combination of the first Gammora Vaccine and Vega viral ingredients. 
These are synthetic petite compounds derived from the HIV enzyme integrate which is responsible for inserting the virus genetic materials into DNA of the infected cell. They simulate the integration of of multiple HIV/DNA  to the extent that triggers self-destruction of the infected cell, called apoptosis.  The peptide produced by San Diego, California-based PolyPeptide Labs, has the potential to cure HIV/AIDS infected patients by destroying all cells carrying the HIV virus-genome. As opposed to the commercial available retroviral treatments , the so-called "cocktail" which merely suppress the spreading of the virus, but do not cure the infection. studies and trials on infected patients(Successful trials) have demonstrated that Gammora is a safe a well-tolerable drug, exhibiting no side-effects. Patients showed a significant increase of the CD4 cell count -up to 99% from the baseline. CD4 cells, also referred to as T cells or T helper cells play an important role in the body's immune system and are an indicator of it's overall health.

Email to this supplier
To

Send

Inquiry Cart(0)